 Home > Medical News > Latest Medical News > Hengrui Medicine Carrelizumab and Famitinib clinical trials approved by FDA

Hengrui Medicine Carrelizumab and Famitinib clinical trials approved by FDA

 Last Update: 2021-03-22
 Source: Internet
 Author: User

Tags

naloxone brand name

brand company

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On March 11, Hengrui Medicine issued an announcement stating that it had recently submitted an application for clinical trials of carrelizumab for injection and famitinib malate capsules to the FDA and was accepted.

Carrelizumab for injection is a humanized anti-PD-1 monoclonal antibody that can bind to human PD-1 receptors and block the PD-1/PD-L1 pathway, restore the body’s anti-tumor immunity, thereby Form the basis of cancer immunotherapy.

Famitinib Malate Capsules is a small molecule multi-target tyrosine kinase inhibitor developed by the company.

At present, the clinical trial has been approved in China and the United States.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.